Table 1. Patient Clinical Characteristics.
Case #1 | Case #2 | Case #3 | |
Age (years) | 66 | 87 | 69 |
Prescribed Dose # of Fxs | 50 Gy in 4 fx | 50 Gy in 5 fx | 48 Gy in 4 fx |
Primary Disease | Lung Adenocarcinoma | Lung Adenocarcinoma | Pancreatic Adenocarcinoma |
Tumor Staging | T3N1M1a | T1bN0M0 | Metastatic |
Location within the Lung | Central | Peripheral | Peripheral |
PTV Coverage Constraint | > 95% @ 50.0 Gy | > 95% @ 50.0 Gy | > 95% @ 48.0 Gy |
Pulmonary Constraint #1 | < 1500 cc @ 11.6 Gy (Both Lungs – GTV) | < 1500 cc @ 12.5 Gy (Both Lungs – GTV) | < 4 cc @ 15.6 Gy PBT |
Pulmonary Constraint #2 | N/A | < 1000 cc @ 13.5Gy (Both Lungs – GTV) | N/A |
Spinal Cord Constraint #1 | Max Dose < 26.0 Gy | Max Dose < 26.0 Gy | < 0.35cc @ 20.8 Gy |
Spinal Cord Constraint #2 | < 0.35 cc @ 20.8 Gy | < 0.25 cc @ 22.5 Gy | < 1.2 cc @ 13.6 Gy |
Spinal Cord Constraint #3 | < 1.2 cc @ 13.6 Gy | < 0.5 cc @ 13.5 Gy | N/A |
Chest Wall / Ribs | N/A | Chest Wall < 30 cc @ 40.0 Gy | Ribs < 1 cc @ 32.0 Gy |
Esophagus | < 5 cc @ 18.8 Gy | < 5 cc @ 27.5 Gy | < 5 cc @ 18.8 Gy |
Heart | < 15 cc @ 28.0 Gy | < 15 cc @ 32.0 Gy | < 15 cc @ 28.0 Gy |
GTV Volume Initial (cc) | 6.91 | 41.39 | 1.91 |
GTV Volume Final (cc) | 8.23 | 36.97 | 1.64 |
GTV Volume % Change | +19% | -11% | -14% |